Malignant Peritoneal Mesothelioma Publication - China

This is an abstract of an article about a mesothelioma study in China.  The article was published at PubMed by the NIH.

Zhang ZG, Hao XS.
Department of General Surgery, Tumor Hospital, Tianjin Medical University, Tianjin 300060, China. doctorchina@eyou.com
Zhonghua Zhong Liu Za Zhi. 2004 Oct;26(10):631-3.

OBJECTIVE: To study the methods of diagnosis and treatment of malignant peritoneal mesothelioma.

METHODS: The clinical data of 41 patients with malignant peritoneal mesothelioma pathologically confirmed were retrospectively analyzed. RESULTS: Of these 41 patients, abdominal pain and diarrhea were found in 38 and 35. The histopathologic types were: epitheloid, fusiform and mixed in 21, 11 and 9 cases. CT was performed in 21 and laparoscopic exploration in 13. The overall surgical resection rate was 70.7%. After operation, local abdominal cavity chemotherapeutic instillation was given in 12, systemic chemotherapy in 23 and immunotherapy in 3. The two year survival rate was 36.6%.

CONCLUSION: For malignant peritoneal mesothelioma, the final diagnosis depends on histological examination and the treatment should be surgical-core combined methods.

Exposure to asbestos is known to cause serious illnesses such as mesothelioma, asbestos-related lung cancer or asbestosis.

If you or a loved one has been diagnosed with an asbestos illness, contact our lawyers today for a free review of your case. A Weitz & Luxenberg representative will contact you as soon as possible.